← 返回

肾细胞癌中 T 细胞耗竭与代谢重编程的趋化因子网络

英文原题:A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma.

查看英文原题

A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma.

PubMed 2023/03/16(内容时间) Front Immunol Q1 · IF 7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

肾细胞癌(RCC)经常被免疫细胞浸润,这一过程受趋化因子调控。RCC肿瘤微环境(TME)中的CD8+ T细胞可能处于耗竭状态,这很可能影响治疗反应和生存。

本研究的目的是评估RCC TME中趋化因子驱动的T细胞募集、T细胞耗竭,以及导致其功能失能的代谢过程。分析了八个公开可用的RCC批量转录组数据集(n=1819)和一个单细胞RNAseq数据集(n=12)。采用了免疫解卷积、半监督聚类、基因集变异分析以及基于蒙特卡洛的代谢反应活性建模。在可用的28个趋化因子基因中,CXCL9/10/11/CXCR3、CXCL13/CXCR5和XCL1/XCR1的mRNA表达在RCC中较正常肾组织显著升高,并且在所有研究数据集中均与肿瘤浸润效应记忆和中央记忆CD8+ T细胞强烈相关。M1 TAM、T细胞、NK细胞以及肿瘤细胞被鉴定为这些趋化因子的主要来源,而T细胞、B细胞和树突状细胞则被发现主要表达相应的受体。以高趋化因子表达和高CD8+ T细胞浸润为特征的RCC聚类显示出IFN/JAK/STAT信号的强烈激活,并伴有多个T细胞耗竭相关转录本的表达升高。趋化因子高表达的RCC以代谢重编程为特征,特别是OXPHOS下调和IDO1介导的色氨酸降解增加。所研究的趋化因子基因均与生存或免疫治疗反应无显著关联。

我们提出一个介导CD8+ T细胞募集的趋化因子网络,并确定T细胞耗竭、能量代谢改变和高IDO1活性是其受到抑制的关键机制。同时靶向耗竭通路和代谢可能成为RCC治疗的有效方法。

展开英文摘要原文

Renal cell carcinoma (RCC) is frequently infiltrated by immune cells, a process which is governed by chemokines. CD8 + T cells in the RCC tumor microenvironment (TME) may be exhausted which most likely influence therapy response and survival. The aim of this study was to evaluate chemokine-driven T cell recruitment, T cell exhaustion in the RCC TME, as well as metabolic processes leading to their functional anergy in RCC. Eight publicly available bulk RCC transcriptome collectives (n=1819) and a single cell RNAseq dataset (n=12) were analyzed. Immunodeconvolution, semi-supervised clustering, gene set variation analysis and Monte Carlo-based modeling of metabolic reaction activity were employed. Among 28 chemokine genes available, CXCL9/10/11/CXCR3, CXCL13/CXCR5 and XCL1/XCR1 mRNA expression were significantly increased in RCC compared to normal kidney tissue and also strongly associated with tumor-infiltrating effector memory and central memory CD8 + T cells in all investigated collectives.

M1 TAMs, T cells, NK cells as well as tumor cells were identified as the major sources of these chemokines, whereas T cells, B cells and dendritic cells were found to predominantly express the cognate receptors. The cluster of RCCs characterized by high chemokine expression and high CD8 + T cell infiltration displayed a strong activation of IFN/JAK/STAT signaling with elevated expression of multiple T cell exhaustion-associated transcripts.

Chemokine high RCCs were characterized by metabolic reprogramming, in particular by downregulated OXPHOS and increased IDO1-mediated tryptophan degradation. None of the investigated chemokine genes was significantly associated with survival or response to immunotherapy.

We propose a chemokine network that mediates CD8 + T cell recruitment and identify T cell exhaustion, altered energy metabolism and high IDO1 activity as key mechanisms of their suppression. Concomitant targeting of exhaustion pathways and metabolism may pose an effective approach to RCC therapy.

论文信息

作者
Pichler R、Siska PJ、Tymoszuk P、Martowicz A、Untergasser G、Mayr R、Weber F、Seeber A
第一作者单位
Department of Urology, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, Innsbruck, Austria.Austria
通讯作者单位
Immunotherapy Unit, Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.Austria
期刊
Frontiers in immunology2023
原文标识
PubMed 37006314 · DOI 10.3389/fimmu.2023.1095195